Skip to main content
Erschienen in: Current Rheumatology Reports 8/2013

01.08.2013 | SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Ankylosing Spondylitis: Chinese Perspective, Clinical Phenotypes, and Associated Extra-articular Systemic Features

verfasst von: Huei-Huang Ho, Ji-Yih Chen

Erschienen in: Current Rheumatology Reports | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Ankylosing spondylitis (AS) is a common rheumatic disease in the Chinese population, which is the largest population in the world associated with the global burden of health care. Herein we review and report the epidemiology and specific clinical characteristics of Chinese AS. More than 90 % of Chinese AS patients are HLA-B27 positive with the predominant HLA-B*2704 subtype; the incidence of HLA-B27 positivity ranges from 4 to 8 % in the general Chinese population. The first-degree relatives of AS probands often develop atypical AS with relatively mild disease and particularly undifferentiated spondyloarthropathy in females. Chinese AS patients have higher frequencies of juvenile-onset AS and peripheral arthritis. Of extra-articular manifestations, AS patients have earlier onset and more recurrent attacks of HLA-B27-related acute anterior uveitis. Cardiac arrhythmias or other cardiovascular disorders and metabolic syndrome are not infrequently found. Importantly, apical lung diseases in Chinese AS patients are also frequently associated with tuberculosis infection.
Literatur
1.
Zurück zum Zitat van der Linden SM, van der Heijde D, Maksymowych WP. Ankylosing spondylitis. In: Firestein GS, Budd RC, Harris Jr ED, et al., editors. Kelley’s Textbook of Rheumatology. Philadelphia: Elsevier Saunders Press; 2009. p. 1169–89.CrossRef van der Linden SM, van der Heijde D, Maksymowych WP. Ankylosing spondylitis. In: Firestein GS, Budd RC, Harris Jr ED, et al., editors. Kelley’s Textbook of Rheumatology. Philadelphia: Elsevier Saunders Press; 2009. p. 1169–89.CrossRef
2.
Zurück zum Zitat •• Ho HH, Yeh SJ, Tsai WP, et al. Paroxysmal supraventricular tachycardia and Wolff–Parkinson–White syndrome in ankylosing spondylitis: a large cohort observation study and literature review. Semin Arthritis Rheum. 2012;42:246–53. This is a recent large cohort clinical study of Chinese patients with AS. Articular, extra-articular features, and pathogenetic associations were described. PubMedCrossRef •• Ho HH, Yeh SJ, Tsai WP, et al. Paroxysmal supraventricular tachycardia and Wolff–Parkinson–White syndrome in ankylosing spondylitis: a large cohort observation study and literature review. Semin Arthritis Rheum. 2012;42:246–53. This is a recent large cohort clinical study of Chinese patients with AS. Articular, extra-articular features, and pathogenetic associations were described. PubMedCrossRef
4.
Zurück zum Zitat Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61 suppl 3:iii 8–iii 18. Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61 suppl 3:iii 8–iii 18.
5.
Zurück zum Zitat Khan MA. Update on spondyloarthropathies. Ann Inter Med. 2002;136:896–907.CrossRef Khan MA. Update on spondyloarthropathies. Ann Inter Med. 2002;136:896–907.CrossRef
6.
Zurück zum Zitat Ng SC, Liao Z, Yu DT, et al. Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum. 2007;37:39–47.PubMedCrossRef Ng SC, Liao Z, Yu DT, et al. Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum. 2007;37:39–47.PubMedCrossRef
7.
Zurück zum Zitat Chou CT, Chen JM, Hsu CM, Chen SJ. HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol. 2003;30:321–5.PubMed Chou CT, Chen JM, Hsu CM, Chen SJ. HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol. 2003;30:321–5.PubMed
8.
Zurück zum Zitat Feltkamp TE, Mardjuadi A, Huang F, Chou CT. Spondyloarthropathies in eastern Asia. Curr Opin Rheumatol. 2001;13:285–90.PubMedCrossRef Feltkamp TE, Mardjuadi A, Huang F, Chou CT. Spondyloarthropathies in eastern Asia. Curr Opin Rheumatol. 2001;13:285–90.PubMedCrossRef
9.
Zurück zum Zitat Zeng QY. Ankylosing spondylitis in Shantou, China: 15 years’ clinical experience. J Rheumatol. 2003;30:1816–21.PubMed Zeng QY. Ankylosing spondylitis in Shantou, China: 15 years’ clinical experience. J Rheumatol. 2003;30:1816–21.PubMed
10.
Zurück zum Zitat Chou CT, Pei L, Chang DM, et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21:302–6.PubMed Chou CT, Pei L, Chang DM, et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21:302–6.PubMed
11.
Zurück zum Zitat Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China. Arthritis Res Ther. 2008;10:R17.PubMedCrossRef Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China. Arthritis Res Ther. 2008;10:R17.PubMedCrossRef
12.
Zurück zum Zitat Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009;29:481–90.PubMedCrossRef Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009;29:481–90.PubMedCrossRef
13.
Zurück zum Zitat Chou CT. Spondyloarthritis in Asian countries- An overview. Curr Rheumatol Rev. 2008;4:81–6.CrossRef Chou CT. Spondyloarthritis in Asian countries- An overview. Curr Rheumatol Rev. 2008;4:81–6.CrossRef
14.
Zurück zum Zitat Nasution AR, Mardjuadi A, Suryadhana NG, et al. Higher relative risk of spondyloarthropathies among B27 positive Indonesian Chinese than native Indonesians. J Rheumatol. 1993;20:988–90.PubMed Nasution AR, Mardjuadi A, Suryadhana NG, et al. Higher relative risk of spondyloarthropathies among B27 positive Indonesian Chinese than native Indonesians. J Rheumatol. 1993;20:988–90.PubMed
15.
Zurück zum Zitat Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum. 1993;22:319–34.PubMedCrossRef Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum. 1993;22:319–34.PubMedCrossRef
16.
Zurück zum Zitat Ma HJ, Yin QF, Hu FP, et al. Different clinical features in patients with ankylosing spondylitis from southern and northern China. Int J Rheum Dis. 2012;15:154–62.PubMedCrossRef Ma HJ, Yin QF, Hu FP, et al. Different clinical features in patients with ankylosing spondylitis from southern and northern China. Int J Rheum Dis. 2012;15:154–62.PubMedCrossRef
17.
Zurück zum Zitat Wei JC, Tsai WC, Lin HS, et al. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford). 2004;43:839–42.CrossRef Wei JC, Tsai WC, Lin HS, et al. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford). 2004;43:839–42.CrossRef
18.
Zurück zum Zitat Robinson WP, van der Linden SM, Khan MA, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989;32:1135–41.PubMedCrossRef Robinson WP, van der Linden SM, Khan MA, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989;32:1135–41.PubMedCrossRef
19.
Zurück zum Zitat Khan MA. Remarkable Polymorphism of HLA-B27: an Ongoing Saga. Curr Rheumatol Report. 2010;12:337–41.CrossRef Khan MA. Remarkable Polymorphism of HLA-B27: an Ongoing Saga. Curr Rheumatol Report. 2010;12:337–41.CrossRef
20.
Zurück zum Zitat Wei JCC. HLA-B27 subtype in Chinese with ankylosing spondylitis (Posters). J Rheumatol 1998 (suppl 54) 1998; 25:27. Wei JCC. HLA-B27 subtype in Chinese with ankylosing spondylitis (Posters). J Rheumatol 1998 (suppl 54) 1998; 25:27.
21.
Zurück zum Zitat Khan MA. HLA and spondyloarthropathies. In: Mehra N, editor. The HLA Complex in Biology and Medicine. New Delhi, India: Jaypee Brothers Medical Publishers; 2010. p. 422–46. Khan MA. HLA and spondyloarthropathies. In: Mehra N, editor. The HLA Complex in Biology and Medicine. New Delhi, India: Jaypee Brothers Medical Publishers; 2010. p. 422–46.
22.
Zurück zum Zitat Gonzalez-Roces S, Alvarez MV, Gonzalez S, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 1997;49:116–22.PubMedCrossRef Gonzalez-Roces S, Alvarez MV, Gonzalez S, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 1997;49:116–22.PubMedCrossRef
23.
Zurück zum Zitat Chen IH, Yang KL, Lee A, et al. Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis. Eur J Immunogenet. 2002;29:435–8.PubMedCrossRef Chen IH, Yang KL, Lee A, et al. Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis. Eur J Immunogenet. 2002;29:435–8.PubMedCrossRef
24.
Zurück zum Zitat van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis with the general population. Arthritis Rheum. 1984;27:241–9.PubMedCrossRef van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis with the general population. Arthritis Rheum. 1984;27:241–9.PubMedCrossRef
25.
Zurück zum Zitat Khan MA, van der Linden SM, Kushner I, et al. Spondylitic disease without evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28:40–3.PubMedCrossRef Khan MA, van der Linden SM, Kushner I, et al. Spondylitic disease without evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28:40–3.PubMedCrossRef
26.
Zurück zum Zitat Chou CT, Lu SJ, Pai L, et al. Family study of ankylosing spondylitis. J Formosan Med Assoc. 1988;87:989–99. Chou CT, Lu SJ, Pai L, et al. Family study of ankylosing spondylitis. J Formosan Med Assoc. 1988;87:989–99.
27.
Zurück zum Zitat Chou CT, Lin KC, Wei JC, et al. Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands. Rheumatology (Oxford). 2005;44:662–5.CrossRef Chou CT, Lin KC, Wei JC, et al. Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands. Rheumatology (Oxford). 2005;44:662–5.CrossRef
28.
Zurück zum Zitat Liu Y, Li J, Chen B, et al. Familial aggregation of ankylosing spondylitis in southern China. J Rheumatol. 2001;28:550–3.PubMed Liu Y, Li J, Chen B, et al. Familial aggregation of ankylosing spondylitis in southern China. J Rheumatol. 2001;28:550–3.PubMed
29.
Zurück zum Zitat Zhao W, Huang F, Xu M, et al. The expression of monokines and their relation with disease activity in patients with juvenile ankylosing spondylitis. Chin J Rheumatol. 2000 (suppl 1):140. Zhao W, Huang F, Xu M, et al. The expression of monokines and their relation with disease activity in patients with juvenile ankylosing spondylitis. Chin J Rheumatol. 2000 (suppl 1):140.
30.
Zurück zum Zitat Zhu J, Lin X, Huang F, et al. Th1/Th2 balances and ankylosing spondylitis. Chin J Rheumatol. 2000;4:202–5. Zhu J, Lin X, Huang F, et al. Th1/Th2 balances and ankylosing spondylitis. Chin J Rheumatol. 2000;4:202–5.
31.
Zurück zum Zitat Chou CT, Uksila J, Toivancn P. Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 1998;16:161–4.PubMed Chou CT, Uksila J, Toivancn P. Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 1998;16:161–4.PubMed
32.
Zurück zum Zitat Howe HS, Zhao L, Song YW, et al. Seronegative spondyloarthropathy—studies from the Asia Pacific region. Ann Acad Med Singapore. 2007;36:135–41.PubMed Howe HS, Zhao L, Song YW, et al. Seronegative spondyloarthropathy—studies from the Asia Pacific region. Ann Acad Med Singapore. 2007;36:135–41.PubMed
33.
Zurück zum Zitat Chen CH, Lin KC, Yu DT, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford). 2006;45:414–20.CrossRef Chen CH, Lin KC, Yu DT, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford). 2006;45:414–20.CrossRef
34.
Zurück zum Zitat Chou CT, Tsai YF, Liu J, et al. The detection of the HLA-B27 antigen by immunomagnetic separation and enzyme-linked immunosorbent assay—comparison with a flow cytometric procedure. J Immunol Methods. 2001;255:15–22.PubMedCrossRef Chou CT, Tsai YF, Liu J, et al. The detection of the HLA-B27 antigen by immunomagnetic separation and enzyme-linked immunosorbent assay—comparison with a flow cytometric procedure. J Immunol Methods. 2001;255:15–22.PubMedCrossRef
35.
Zurück zum Zitat Chen HA, Chen CH, Lin YJ, et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol. 2010;37:2126–32.PubMedCrossRef Chen HA, Chen CH, Lin YJ, et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol. 2010;37:2126–32.PubMedCrossRef
36.
Zurück zum Zitat Chen HA, Chen CH, Liao HT, et al. Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J Rheumatol. 2012;15:1013–8.CrossRef Chen HA, Chen CH, Liao HT, et al. Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J Rheumatol. 2012;15:1013–8.CrossRef
37.
Zurück zum Zitat O’Shea FD, Boyle E, Riarh R, et al. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis. 2009;68:1407–12.PubMedCrossRef O’Shea FD, Boyle E, Riarh R, et al. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis. 2009;68:1407–12.PubMedCrossRef
38.
Zurück zum Zitat Huang F, Zhang J, Zhu J, et al. Juvenile spondyloarthropathies: the Chinese experience. Rheum Dis Clin North Am. 2003;29:531–47.PubMedCrossRef Huang F, Zhang J, Zhu J, et al. Juvenile spondyloarthropathies: the Chinese experience. Rheum Dis Clin North Am. 2003;29:531–47.PubMedCrossRef
39.
Zurück zum Zitat Maksymowych WP, Chou CT, Russell AS. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis. 1995;54:128–30.PubMedCrossRef Maksymowych WP, Chou CT, Russell AS. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis. 1995;54:128–30.PubMedCrossRef
40.
Zurück zum Zitat Heuft-Dorenbosch L. vanTubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum. 2004;51:154–9.PubMedCrossRef Heuft-Dorenbosch L. vanTubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum. 2004;51:154–9.PubMedCrossRef
41.
Zurück zum Zitat Vander Cruyssen B, Munoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford). 2010;49:73–81.CrossRef Vander Cruyssen B, Munoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford). 2010;49:73–81.CrossRef
42.
Zurück zum Zitat Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001;28:2283–8.PubMed Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001;28:2283–8.PubMed
43.
Zurück zum Zitat Lin Z, Gu J, He P, et al. Multicenter validation of BASDAI and BASFI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int. 2011;31:233–8.PubMedCrossRef Lin Z, Gu J, He P, et al. Multicenter validation of BASDAI and BASFI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int. 2011;31:233–8.PubMedCrossRef
44.
Zurück zum Zitat Chen CH, Lin KC, Chen HA, et al. Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan. Clin Rheumatol. 2007;26:953–7.PubMedCrossRef Chen CH, Lin KC, Chen HA, et al. Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan. Clin Rheumatol. 2007;26:953–7.PubMedCrossRef
45.
Zurück zum Zitat Chung YM, Liao HT, Lin KC, et al. Prevalence of spondyloarthropathies in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38:84–90.PubMedCrossRef Chung YM, Liao HT, Lin KC, et al. Prevalence of spondyloarthropathies in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38:84–90.PubMedCrossRef
46.
Zurück zum Zitat Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014–27.PubMedCrossRef Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014–27.PubMedCrossRef
47.
Zurück zum Zitat Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med. 1997;12(8 Pt 1):621–9.CrossRef Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med. 1997;12(8 Pt 1):621–9.CrossRef
48.
Zurück zum Zitat O’Neill TW, Bresnihan B. The heart in ankylosing spondylitis. Ann Rheum Dis. 1992;51:705–6.PubMedCrossRef O’Neill TW, Bresnihan B. The heart in ankylosing spondylitis. Ann Rheum Dis. 1992;51:705–6.PubMedCrossRef
49.
Zurück zum Zitat Lautermann D, Braun J. Ankylosing spondylitis—Cardiac manifestations. Clin Exp Rheumatol. 2002;20 Suppl 28:S11–5.PubMed Lautermann D, Braun J. Ankylosing spondylitis—Cardiac manifestations. Clin Exp Rheumatol. 2002;20 Suppl 28:S11–5.PubMed
50.
Zurück zum Zitat Gould BA, Turner J, Keeling DH, et al. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227–32.PubMedCrossRef Gould BA, Turner J, Keeling DH, et al. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227–32.PubMedCrossRef
51.
Zurück zum Zitat Heeneman S, Daemen MJ. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol. 2007;19:358–62.PubMedCrossRef Heeneman S, Daemen MJ. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol. 2007;19:358–62.PubMedCrossRef
52.
Zurück zum Zitat Yildirir A, Aksoyek S, Calguneri M, et al. QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatol (Oxford). 2000;39:875–9.CrossRef Yildirir A, Aksoyek S, Calguneri M, et al. QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatol (Oxford). 2000;39:875–9.CrossRef
53.
Zurück zum Zitat Han C, Robinson Jr DW, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167–72.PubMed Han C, Robinson Jr DW, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167–72.PubMed
54.
Zurück zum Zitat Toussirot E, Bahjaoui-Bouhaddi M, Poncet JC, et al. Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis. 1999;58:481–7.PubMedCrossRef Toussirot E, Bahjaoui-Bouhaddi M, Poncet JC, et al. Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis. 1999;58:481–7.PubMedCrossRef
55.
Zurück zum Zitat Wei JC, Jan MS, Yu CT, et al. Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:739–42.PubMedCrossRef Wei JC, Jan MS, Yu CT, et al. Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:739–42.PubMedCrossRef
56.
Zurück zum Zitat Feltelius N, Hedenström H, Hillerdal G, Hällgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis. 1986;45:736–40.PubMedCrossRef Feltelius N, Hedenström H, Hillerdal G, Hällgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis. 1986;45:736–40.PubMedCrossRef
57.
Zurück zum Zitat Hamilton KA. Pulmonary disease manifestations of ankylosing spondylitis. Ann Intern Med. 1949;31:216–27.PubMedCrossRef Hamilton KA. Pulmonary disease manifestations of ankylosing spondylitis. Ann Intern Med. 1949;31:216–27.PubMedCrossRef
58.
Zurück zum Zitat Rosenow E, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc. 1977;52:641–9.PubMed Rosenow E, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc. 1977;52:641–9.PubMed
59.
Zurück zum Zitat Hillerdal G. Ankylosing spondylitis lung disease—an underdiagnosed entity? Eur J Respir Dis. 1983;64:437–41.PubMed Hillerdal G. Ankylosing spondylitis lung disease—an underdiagnosed entity? Eur J Respir Dis. 1983;64:437–41.PubMed
60.
Zurück zum Zitat Ho HH, Lin MC, Yu KH, et al. Pulmonary tuberculosis and disease-related pulmonary apical fibrosis in ankylosing spondylitis. J Rheumatol. 2009;36:355–60.PubMedCrossRef Ho HH, Lin MC, Yu KH, et al. Pulmonary tuberculosis and disease-related pulmonary apical fibrosis in ankylosing spondylitis. J Rheumatol. 2009;36:355–60.PubMedCrossRef
61.
Zurück zum Zitat Casserly IP, Fenlon HM, Breatnach E, Sant SM. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis—correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol. 1997;36:677–82.PubMedCrossRef Casserly IP, Fenlon HM, Breatnach E, Sant SM. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis—correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol. 1997;36:677–82.PubMedCrossRef
62.
Zurück zum Zitat El Maghraoui A, Chaouir S, Bezza A, et al. Thoracic high resolution computed tomography in patients with ankylosing spondylitis and without respiratory symptoms. Ann Rheum Dis. 2003;62:1856.CrossRef El Maghraoui A, Chaouir S, Bezza A, et al. Thoracic high resolution computed tomography in patients with ankylosing spondylitis and without respiratory symptoms. Ann Rheum Dis. 2003;62:1856.CrossRef
63.
Zurück zum Zitat Lee CC, Lee SH, Chang IJ, et al. Spontaneous pneumothorax associated with ankylosing spondylitis. Rheumatology (Oxford). 2005;44:1538–41.CrossRef Lee CC, Lee SH, Chang IJ, et al. Spontaneous pneumothorax associated with ankylosing spondylitis. Rheumatology (Oxford). 2005;44:1538–41.CrossRef
64.
Zurück zum Zitat Solak O, Fidan F, Dünder U, et al. The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rheumatology (Oxford). 2009;48:433–5.CrossRef Solak O, Fidan F, Dünder U, et al. The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rheumatology (Oxford). 2009;48:433–5.CrossRef
65.
Zurück zum Zitat Erb N, Karokis D, Demamere JP, et al. Obstructive sleep apnea as a cause of fatigue in ankylosing spondylitis. Ann Rheum Dis. 2003;62:183–4.PubMedCrossRef Erb N, Karokis D, Demamere JP, et al. Obstructive sleep apnea as a cause of fatigue in ankylosing spondylitis. Ann Rheum Dis. 2003;62:183–4.PubMedCrossRef
66.
Zurück zum Zitat Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Medicine. 2012;13:583–8.PubMedCrossRef Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Medicine. 2012;13:583–8.PubMedCrossRef
67.
Zurück zum Zitat Malesci D, Niglio A, Mennillo GA, et al. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710–4.PubMedCrossRef Malesci D, Niglio A, Mennillo GA, et al. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710–4.PubMedCrossRef
68.
Zurück zum Zitat van Halm VP, van Denderen JC, Peters MJ, et al. Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis. 2006;65:1473–7.PubMedCrossRef van Halm VP, van Denderen JC, Peters MJ, et al. Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis. 2006;65:1473–7.PubMedCrossRef
69.
Zurück zum Zitat Ho HH, Yu KH, Chen JY, et al. Coexisting ankylosing spondylitis and gouty arthritis. Clin Rheumatol. 2007;26:1655–61.PubMedCrossRef Ho HH, Yu KH, Chen JY, et al. Coexisting ankylosing spondylitis and gouty arthritis. Clin Rheumatol. 2007;26:1655–61.PubMedCrossRef
70.
Zurück zum Zitat Beauvais C, Kaplan G, Mougenot B, et al. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis. 1993;52:61–2.PubMedCrossRef Beauvais C, Kaplan G, Mougenot B, et al. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis. 1993;52:61–2.PubMedCrossRef
71.
Zurück zum Zitat Lam SM, Ho HH, Dunn P, Luo SF. Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations. J Formosan Med Assoc. 1989;88:726–8. Lam SM, Ho HH, Dunn P, Luo SF. Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations. J Formosan Med Assoc. 1989;88:726–8.
72.
Zurück zum Zitat O’Neill TW, Harrison BJ, Yin AL, Holt PJ. Ankylosing spondylitis associated with IgA lambda chain myeloma. Br J Rheumatol 1007; 36:401–2. O’Neill TW, Harrison BJ, Yin AL, Holt PJ. Ankylosing spondylitis associated with IgA lambda chain myeloma. Br J Rheumatol 1007; 36:401–2.
73.
Zurück zum Zitat Borman P, Bodur H, Ak G, et al. The coexistence of Behcet’s disease and ankylosing spondylitis. Rheumatol Int. 2000;19:195–8.PubMedCrossRef Borman P, Bodur H, Ak G, et al. The coexistence of Behcet’s disease and ankylosing spondylitis. Rheumatol Int. 2000;19:195–8.PubMedCrossRef
74.
Zurück zum Zitat Peluso R, Lupoli GA, Del Puente A, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7.PubMedCrossRef Peluso R, Lupoli GA, Del Puente A, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7.PubMedCrossRef
75.
Zurück zum Zitat Kobak S, Kobak AC, Kabasakal Y, et al. Sjögren’s syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:173–5.PubMedCrossRef Kobak S, Kobak AC, Kabasakal Y, et al. Sjögren’s syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:173–5.PubMedCrossRef
76.
Zurück zum Zitat Borman P, Ayhan F, Okumus M. Coexistence of rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int. 2010;30:127–9.CrossRef Borman P, Ayhan F, Okumus M. Coexistence of rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int. 2010;30:127–9.CrossRef
77.
Zurück zum Zitat Brandt J, Maier T, Rudwaleit M, et al. Co-occurrence of spondyloarthropathy and connective tissue disease (MCTD) in a patient with ankylosing spondylitis. Clin Exp Rheumatol. 2002;20:80–4.PubMed Brandt J, Maier T, Rudwaleit M, et al. Co-occurrence of spondyloarthropathy and connective tissue disease (MCTD) in a patient with ankylosing spondylitis. Clin Exp Rheumatol. 2002;20:80–4.PubMed
78.
Zurück zum Zitat Akkoc N, Sari I, Birlik M, et al. Ankylosing spondylitis and spondyloarthropathy presenting with clinical picture of adult onset Still’s disease: case series. Rheumatology (Oxford). 2008;47:1436–7.CrossRef Akkoc N, Sari I, Birlik M, et al. Ankylosing spondylitis and spondyloarthropathy presenting with clinical picture of adult onset Still’s disease: case series. Rheumatology (Oxford). 2008;47:1436–7.CrossRef
79.
Zurück zum Zitat Haibel H, Brandt J, Rudwaleit M, et al. Treatment of active ankylosing spondylitis with pamidronate. Rheumatology (Oxford). 2003;42:1018–20.CrossRef Haibel H, Brandt J, Rudwaleit M, et al. Treatment of active ankylosing spondylitis with pamidronate. Rheumatology (Oxford). 2003;42:1018–20.CrossRef
80.
Zurück zum Zitat Huang F, Gu J, Zhao W, et al. One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum. 2002;47:249–54.PubMedCrossRef Huang F, Gu J, Zhao W, et al. One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum. 2002;47:249–54.PubMedCrossRef
81.
Zurück zum Zitat Wei JC, Chan TW, Lin HS, et al. Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. J Rheumatol. 2003;30:2627–31.PubMed Wei JC, Chan TW, Lin HS, et al. Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. J Rheumatol. 2003;30:2627–31.PubMed
82.
Zurück zum Zitat Deng X, Zhang J, Zhang J, Huang F. Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept. Rheumatol Int. 2012; 2012 Nov 11. [Epub ahead of print] Deng X, Zhang J, Zhang J, Huang F. Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept. Rheumatol Int. 2012; 2012 Nov 11. [Epub ahead of print]
83.
Zurück zum Zitat Chou CT. The clinical application of etanercept in Chinese patients with rheumatic diseases. Mod Rheumatol. 2006;16:206–13.PubMedCrossRef Chou CT. The clinical application of etanercept in Chinese patients with rheumatic diseases. Mod Rheumatol. 2006;16:206–13.PubMedCrossRef
84.
Zurück zum Zitat Huang F, Gu J, Zhu P et al. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial. Ann Rheum Dis. 2013 Mar 8. [Epub ahead of print] Huang F, Gu J, Zhu P et al. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial. Ann Rheum Dis. 2013 Mar 8. [Epub ahead of print]
85.
Zurück zum Zitat Bao C, Huang F, Khan MA, et al. Safety and Efficacy of Golimumab in Chinese Patients with Active Ankylosing Spondylitis: 1-Year Results of a Multicenter, Randomized, Double-Blind, Placebo- Controlled Phase III Trial. Submitted for publication. Bao C, Huang F, Khan MA, et al. Safety and Efficacy of Golimumab in Chinese Patients with Active Ankylosing Spondylitis: 1-Year Results of a Multicenter, Randomized, Double-Blind, Placebo- Controlled Phase III Trial. Submitted for publication.
Metadaten
Titel
Ankylosing Spondylitis: Chinese Perspective, Clinical Phenotypes, and Associated Extra-articular Systemic Features
verfasst von
Huei-Huang Ho
Ji-Yih Chen
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Current Rheumatology Reports / Ausgabe 8/2013
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-013-0344-0

Weitere Artikel der Ausgabe 8/2013

Current Rheumatology Reports 8/2013 Zur Ausgabe

VASCULITIS (LR ESPINOZA, SECTION EDITOR)

IgG4-Associated Vasculitis

INFLAMMATORY MUSCLE DISEASE (I LUNDBERG, SECTION EDITOR)

Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome

SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Advances in the Genetics of Spondyloarthritis and Clinical Implications

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.